Avian Competitive Intelligence Blog What the market can bear: Pharma companies experiment on drug pricing

Just last week, 155 doctors in the US endorsed a proposal to control the soaring prices of cancer medicines, noting that "In the United States, the average price of new cancer drugs increased 5- to 10-fold over 15 years, to more than $100,000 per year in 2012. A study by Howard et al documented the [...]